These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 28562258)
21. [Research of optimal dosing regimens and therapeutic drug monitoring for vancomycin by clinical pharmacists: analysis of 7-year data]. Xu G; Chen E; Mao E; Che Z; He J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):640-645. PubMed ID: 30045790 [TBL] [Abstract][Full Text] [Related]
22. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines. Kullar R; Leonard SN; Davis SL; Delgado G; Pogue JM; Wahby KA; Falcione B; Rybak MJ Pharmacotherapy; 2011 May; 31(5):441-8. PubMed ID: 21923425 [TBL] [Abstract][Full Text] [Related]
24. A randomized controlled trial of a vancomycin loading dose in children. Demirjian A; Finkelstein Y; Nava-Ocampo A; Arnold A; Jones S; Monuteaux M; Sandora TJ; Patterson A; Harper MB Pediatr Infect Dis J; 2013 Nov; 32(11):1217-23. PubMed ID: 23817340 [TBL] [Abstract][Full Text] [Related]
25. Vancomycin population pharmacokinetics in neonates. de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244 [TBL] [Abstract][Full Text] [Related]
26. Sustained improvement in vancomycin dosing and monitoring post-implementation of guidelines: Results of a three-year follow-up after a multifaceted intervention in an Australian teaching hospital. Phillips CJ; McKinnon RA; Woodman RJ; Gordon DL J Infect Chemother; 2018 Feb; 24(2):103-109. PubMed ID: 29037461 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations. Mehrotra N; Tang L; Phelps SJ; Meibohm B Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303 [TBL] [Abstract][Full Text] [Related]
28. Automating Vancomycin Monitoring to Improve Patient Safety. Mishra V; Chouinard M; Keiser J; Wagner B; Yen MS; Banas C; Dow A Jt Comm J Qual Patient Saf; 2019 Nov; 45(11):757-762. PubMed ID: 31526711 [TBL] [Abstract][Full Text] [Related]
29. Pediatric Antibiotic Stewardship: Optimization of Vancomycin Therapy Based on Individual Pharmacokinetics. Kreitmeyr K; Pecar A; Mikolajczyk R; von Both U; Huebner J Pediatr Infect Dis J; 2021 Jun; 40(6):556-562. PubMed ID: 33956756 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of Treatment Courses When Vancomycin Is Given Every 8 Hours in Adult Patients. Brumer E; Dubrovskaya Y; Scipione MR; Aberle C; Rahimian J; Papadopoulos J J Pharm Pract; 2015 Dec; 28(6):511-7. PubMed ID: 25112304 [TBL] [Abstract][Full Text] [Related]
31. [Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit]. Villena R; González CA; Nalegach ME; Vásquez A; Villareal M; Drago M Rev Chilena Infectol; 2014 Jun; 31(3):249-53. PubMed ID: 25146197 [TBL] [Abstract][Full Text] [Related]
32. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study. Matson KL; Shaffer CL; Beck GL; Simonsen KA Pharmacotherapy; 2015 Mar; 35(3):337-43. PubMed ID: 25756622 [TBL] [Abstract][Full Text] [Related]
33. Pediatric vancomycin dosing: Trends over time and the impact of therapeutic drug monitoring. Balch AH; Constance JE; Thorell EA; Stockmann C; Korgenski EK; Campbell SC; Spigarelli MG; Sherwin CM J Clin Pharmacol; 2015 Feb; 55(2):212-20. PubMed ID: 25264036 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of a pediatric continuous-infusion vancomycin therapy guideline. McKamy S; Chen T; Lee M; Ambrose PJ Am J Health Syst Pharm; 2012 Dec; 69(23):2066-71. PubMed ID: 23172265 [TBL] [Abstract][Full Text] [Related]
35. Trough concentrations of vancomycin: adult therapeutic targets are not appropriate for children. Gordon CL; Thompson C; Carapetis JR; Turnidge J; Kilburn C; Currie BJ Pediatr Infect Dis J; 2012 Dec; 31(12):1269-71. PubMed ID: 22828642 [TBL] [Abstract][Full Text] [Related]
36. Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients. Morrill HJ; Caffrey AR; Noh E; LaPlante KL Pharmacotherapy; 2015 Sep; 35(9):869-75. PubMed ID: 26343549 [TBL] [Abstract][Full Text] [Related]
37. Performance of a divided-load intravenous vancomycin dosing strategy for critically ill patients. Denetclaw TH; Dowling TC; Steinke D Ann Pharmacother; 2013 Dec; 47(12):1611-7. PubMed ID: 24259632 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of a vancomycin dosing nomogram in achieving high target trough concentrations in Taiwanese patients. Leu WJ; Liu YC; Wang HW; Chien HY; Liu HP; Lin YM Int J Infect Dis; 2012 Nov; 16(11):e804-10. PubMed ID: 22917921 [TBL] [Abstract][Full Text] [Related]
39. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software. Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786 [TBL] [Abstract][Full Text] [Related]
40. Special considerations for monitoring vancomycin concentrations in pediatric patients. Miles MV; Li L; Lakkis H; Youngblood J; McGinnis P Ther Drug Monit; 1997 Jun; 19(3):265-70. PubMed ID: 9200765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]